Skip to main content
. 2017 Nov 30;103(6):1065–1072. doi: 10.3324/haematol.2017.175687

Figure 4.

Figure 4.

Modulation of the exchanger function of AE2 driven by p17AE2 peptide. (A) Basal pHi in human peripheral blood B lymphocytes (PBLs) and tumor B-cell lines. (B) Changes in pHi values upon treatment with p17AE2. (C) Average basal pHi in sensitive and resistant tumor B-cell lines. (D-E) Effect of p17AE2 treatment on the AE2 activity in sensitive Jeko1 and resistant U266 cell lines. ***P<0.001.